Renaissance Technologies
BSPM

Renaissance Technologies’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Renaissance Technologies’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-105,956
Closed -$468K – 3666
2016
Q2 		$468K Buy
105,956
+1,100
+1% +$2.45K ﹤0.01% 2817
2016
Q1 		$200K Buy
104,856
+3,803
+4% +$8.64K ﹤0.01% 3088
2015
Q4 		$284K Buy
101,053
+1,686
+2% +$7.28K ﹤0.01% 2899
2015
Q3 		$485K Buy
99,367
+2,243
+2% +$12.2K ﹤0.01% 2640
2015
Q2 		$707K Buy
97,124
+6,714
+7% +$60.1K ﹤0.01% 2608
2015
Q1 		$772K Buy
90,410
+4,200
+5% +$33.8K ﹤0.01% 2431
2014
Q4 		$706K Buy
86,210
+1,257
+1% +$12K ﹤0.01% 2311
2014
Q3 		$957K Buy
84,953
+4,429
+6% +$49.3K ﹤0.01% 2050
2014
Q2 		$817K Buy
80,524
+3,228
+4% +$35.7K ﹤0.01% 2132
2014
Q1 		$1.09M Buy
77,296
+31,561
+69% +$500K ﹤0.01% 2034
2013
Q4 		$663K Buy
45,735
+17,682
+63% +$191K ﹤0.01% 2262
2013
Q3 		$147K Buy
28,053
+1,100
+4% +$6.03K ﹤0.01% 2640
2013
Q2 		$130K Buy
+26,953
New +$150K ﹤0.01% 2594

Other funds holding BSPM

AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies's BSPM Position: Q3 2016 in Review

Renaissance Technologies sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2016, closing a stake of 105,956 shares — an estimated $468K sold.

Renaissance Technologies first reported a position in BSPM in Q2 2013 and held it in 13 quarters. The position peaked at $1.09M in Q1 2014. 8 funds tracked by Wall St. Rank hold BSPM as of Q3 2016.

  • Renaissance Technologies reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Renaissance Technologies sold 105,956 Biostar Pharmaceuticals, Inc. shares in Q3 2016, an estimated $468K.
  • Renaissance Technologies first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • Renaissance Technologies's Biostar Pharmaceuticals, Inc. position peaked at $1.09M in Q1 2014.
  • 8 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2016.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.